Healthcare professionals endorse the return of sales reps into hospitals (with some new guidelines of course).

Support grows for return of medtech reps to hospitals (MassDevice)

Twenty-six more medical and surgical societies and healthcare associations have endorsed guidelines for the safe return of medtech company representatives to healthcare facilities during the coronavirus pandemic. The guidance, released in May by AdvaMed, the Association of periOperative Registered Nurses (AORN) and the American Hospital Association (AHA), builds on the April 17 joint statement by AHA, AORN, the American College of Surgeons and the American Society of Anesthesiologists on the resumption of elective surgeries. The guidance outlines ways to support the collaboration between healthcare personnel and medtech representatives as healthcare facilities consider when and how to safely resume elective surgeries paused during the pandemic. Several medical device companies, especially those in orthopedics, have suffered major drops in sales since the Centers for Medicare and Medicaid Services (CMS) recommended in March that healthcare providers postpone elective procedures until further notice to preserve personal protective equipment. The CMS decision followed one by the Amer...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top